Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
PremiumThe FlySpyre Therapeutics price target raised to $65 from $50 at Guggenheim
15d ago
Takeda and BMC team on decarbonization across health care ecosystem
Premium
The Fly
Takeda and BMC team on decarbonization across health care ecosystem
16d ago
Takeda, Astellas Pharma and Sumitomo Mitsui form early drug discovery JV
Premium
The Fly
Takeda, Astellas Pharma and Sumitomo Mitsui form early drug discovery JV
1M ago
Takeda receives European Commission approval for ADZYNMA
PremiumThe FlyTakeda receives European Commission approval for ADZYNMA
3M ago
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
Premium
The Fly
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
3M ago
AI Could Revolutionize Drug Discovery: A Look at Key Players 
Premium
Market News
AI Could Revolutionize Drug Discovery: A Look at Key Players 
4M ago
Takeda: Japanese MHLW approves LIVTENCITY
PremiumThe FlyTakeda: Japanese MHLW approves LIVTENCITY
5M ago
Takeda receives approval from European Commission for FRUZAQLA
Premium
The Fly
Takeda receives approval from European Commission for FRUZAQLA
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100